Is Anti-VEGF Monotherapy Best for Diabetic Macular Edema?

by Medscape • 2016/09/10 • 0 Comments

One of the predictors of visual improvement in patients with diabetic macular edema is ranibizumab monotherapy, an analysis of the RESTORE data shows, but not everyone agrees with the findings.
Medscape Medical News

← D.C. Week: CMS Eases MACRA Pain for Doctors

Two Studies Demonstrate Promising Results of PiXL™ Procedure (Photorefractive Intrastromal Corneal Collagen Cross-Linking) for Non-Invasive Treatment of Low Myopia →

Post navigation